Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis

NCT00004794 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2005-06-24

No results posted yet for this study

Summary

OBJECTIVES: I. Evaluate the safety and efficacy of intravenous cidofovir in patients with small peripheral cytomegalovirus retinitis.

II. Obtain safety and efficacy data related to different dosages of cidofovir.

Conditions

  • Cytomegalovirus Retinitis
  • Acquired Immunodeficiency Syndrome

Interventions

DRUG

cidofovir

Sponsors & Collaborators

Principal Investigators

  • David V. Weinberg · Northwestern University

Study Design

Purpose
TREATMENT

Eligibility

Min Age
13 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-03-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004794 on ClinicalTrials.gov